ARRAY BIOPHARMA INC - NOTE 3.000% 6/0

Historical Holders from Q1 2014 to Q4 2017

Type / Class
Debt / NOTE 3.000% 6/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ARRAY BIOPHARMA INC - NOTE 3.000% 6/0 across Reporting Periods

Period Principal Value Change Price (% of par) Investors
2017 Q4 $0 $0 -$234,027,000 0
2017 Q3 $129,339,000 $234,027,000 +$4,151,329 180.72% 14
2017 Q2 $130,856,000 $177,452,000 -$5,415,784 135.71% 13
2017 Q1 $132,552,000 $188,829,000 +$790,263 142.28% 16
2016 Q4 $132,463,000 $185,027,000 +$2,518,116 139.85% 18
2016 Q3 $133,956,000 $159,253,000 +$12,222,388 118.38% 23
2016 Q2 $130,401,740 $112,027,000 +$203,105 84.93% 22
2016 Q1 $130,554,870 $106,126,000 +$20,548,429 80.11% 19
2015 Q4 $107,417,534 $100,813,633 -$22,421,950 93.11% 19
2015 Q3 $131,122,000 $128,530,000 -$3,999,020 98.56% 19
2015 Q2 $133,833,000 $169,441,000 +$5,107,989 126.67% 19
2015 Q1 $129,764,000 $162,630,000 +$6,548,656 125.59% 16
2014 Q4 $128,614,000 $119,693,000 -$3,670,735 93.45% 17
2014 Q3 $110,010,000 $97,288,000 -$5,126,008 88.53% 16
2014 Q2 $115,374,000 $114,002,000 -$7,230,720 100.12% 15
2014 Q1 $122,569,000 $126,591,000 -$11,155,338 102.99% 15